entity
58 results
1 - 58
entity
covered entity
new molecular entity
tort
NME
fragment
culture
party
silo
group
protein
fraction
angioinvasion
individually identifiable health information
plaintiff
dissolution
leptotene
variant
per
loudness
bind
value
compensable
third-party payer
nanobacteria
defendant
dial
B-cell lymphoblastic leukemia-lymphoblastic lymphoma
communication
hospital
B-cell acute lymphoblastic leukemia-lymphoblastic lymphoma
dualism
appendicitis
distribution
contract research organization
statutes of limitations
holism
striatum
complementary
decrement
diagnostic
hypotension
atom
substance
Controlled Substances Schedules
protected health information
R
self-governance
psychosomatic
practice
sacubitril/valsartan
complex
Laryngotracheobronchitis (Croup)
dehiscence
vertigo
Differences in U.S. and Canadian Pharmaceutical Practices



